Filing Details

Accession Number:
0001181431-13-011488
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-21 18:49:09
Reporting Period:
2012-11-02
Filing Date:
2013-02-21
Accepted Time:
2013-02-21 18:49:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1365216 Sucampo Pharmaceuticals Inc. SCMP Pharmaceutical Preparations (2834) 133929237
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1384384 S&R Technology Holdings, Llc 7501 Wisconsin Avenue
Suite 600E
Bethesda MD 20814-6519
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2012-11-02 867 $5.00 25,545,501 No 4 S Direct
Class A Common Stock Disposition 2013-01-08 29,307 $5.00 25,516,194 No 4 S Direct
Class A Common Stock Disposition 2013-02-19 38,462 $5.14 25,477,732 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2012.
  2. The prices reported are weighted average prices. The shares sold on January 8, 2013 were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The shares sold on February 19, 2013 were sold in multiple transactions at prices ranging from $5.10 to $5.24, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.